ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Crizotinib API Market Research Report 2026
Published Date: 2026-02-13
|
Report Code: QYRE-Auto-16C18035
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Crizotinib API Market Research Report 2024
BUY CHAPTERS

Global Crizotinib API Market Research Report 2026

Code: QYRE-Auto-16C18035
Report
2026-02-13
Pages:133
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
MSN Laboratories
Greencross
Hetero Labs
Apothecon Pharmaceuticals
Tocris Bioscience
Selleck Chemicals
Cayman Chemical
Anant Pharmaceuticals
AdooQ BioScience
Focus Biomolecules
LC Laboratories
Hefei Home Sunshine Pharmaceutical Technology
Vama Lifecare
Croissance Biomed
Medicine House
Chongqing Huapont Shengchem Pharm
Xuzhou Wanbang Jinqiao Pharmaceutical

Crizotinib API Market

The global Crizotinib API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Crizotinib API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Crizotinib is an active pharmaceutical ingredient (API) used as a targeted therapy for cancers with ALK gene alterations,primarily non-small cell lung cancer (NSCLC).It works by inhibiting the ALK protein, which is involved in tumor growth.
The North American market for Crizotinib API is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Crizotinib API is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Crizotinib API include MSN Laboratories, Greencross, Hetero Labs, Vama Lifecare, Croissance Biomed, Medicine House, Apothecon Pharmaceuticals, Tocris Bioscience, Selleck Chemicals, Cayman Chemical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Crizotinib API market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Crizotinib API. The Crizotinib API market size, estimates, and forecasts are provided in terms of sales volume (kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Crizotinib API market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Crizotinib API manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Crizotinib API Market Report

Report Metric Details
Report Name Crizotinib API Market
Segment by Type
  • Purity≥99%
  • Purity<99%
by Application
  • Online Sales
  • Offline Sales
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company MSN Laboratories, Greencross, Hetero Labs, Vama Lifecare, Croissance Biomed, Medicine House, Apothecon Pharmaceuticals, Tocris Bioscience, Selleck Chemicals, Cayman Chemical, Anant Pharmaceuticals, Adooq Bioscience, Focus Biomolecules, LC Laboratories, Hefei Home Sunshine Pharmaceutical Technology, Chongqing Huapont Shengchem Pharm, Xuzhou Wanbang Jinqiao Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Crizotinib API manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Crizotinib API sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Crizotinib API Market report?

Ans: The main players in the Crizotinib API Market are MSN Laboratories, Greencross, Hetero Labs, Vama Lifecare, Croissance Biomed, Medicine House, Apothecon Pharmaceuticals, Tocris Bioscience, Selleck Chemicals, Cayman Chemical, Anant Pharmaceuticals, Adooq Bioscience, Focus Biomolecules, LC Laboratories, Hefei Home Sunshine Pharmaceutical Technology, Chongqing Huapont Shengchem Pharm, Xuzhou Wanbang Jinqiao Pharmaceutical

What are the Application segmentation covered in the Crizotinib API Market report?

Ans: The Applications covered in the Crizotinib API Market report are Online Sales, Offline Sales

What are the Type segmentation covered in the Crizotinib API Market report?

Ans: The Types covered in the Crizotinib API Market report are Purity≥99%, Purity<99%

1 Crizotinib API Market Overview
1.1 Product Definition
1.2 Crizotinib API by Type
1.2.1 Global Crizotinib API Market Value by Type: 2025 vs 2032
1.2.2 Purity≥99%
1.2.3 Purity<99%
1.3 Crizotinib API by Application
1.3.1 Global Crizotinib API Market Value by Application: 2025 vs 2032
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Crizotinib API Market Size Estimates and Forecasts
1.4.1 Global Crizotinib API Revenue 2021–2032
1.4.2 Global Crizotinib API Sales 2021–2032
1.4.3 Global Crizotinib API Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Crizotinib API Market Competition by Manufacturers
2.1 Global Crizotinib API Sales Market Share by Manufacturers (2021–2026)
2.2 Global Crizotinib API Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Crizotinib API Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Crizotinib API, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Crizotinib API, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Crizotinib API, Product Types and Applications
2.7 Global Key Manufacturers of Crizotinib API, Date of Entry into the Industry
2.8 Global Crizotinib API Market Competitive Situation and Trends
2.8.1 Global Crizotinib API Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Crizotinib API Players Market Share by Revenue
2.8.3 Global Crizotinib API Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Crizotinib API Market Scenario by Region
3.1 Global Crizotinib API Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Crizotinib API Sales by Region: 2021–2032
3.2.1 Global Crizotinib API Sales by Region: 2021–2026
3.2.2 Global Crizotinib API Sales by Region: 2027–2032
3.3 Global Crizotinib API Revenue by Region: 2021–2032
3.3.1 Global Crizotinib API Revenue by Region: 2021–2026
3.3.2 Global Crizotinib API Revenue by Region: 2027–2032
3.4 North America Crizotinib API Market Facts & Figures by Country
3.4.1 North America Crizotinib API Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Crizotinib API Sales by Country (2021–2032)
3.4.3 North America Crizotinib API Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Crizotinib API Market Facts & Figures by Country
3.5.1 Europe Crizotinib API Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Crizotinib API Sales by Country (2021–2032)
3.5.3 Europe Crizotinib API Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Crizotinib API Market Facts & Figures by Region
3.6.1 Asia Pacific Crizotinib API Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Crizotinib API Sales by Region (2021–2032)
3.6.3 Asia Pacific Crizotinib API Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Crizotinib API Market Facts & Figures by Country
3.7.1 Latin America Crizotinib API Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Crizotinib API Sales by Country (2021–2032)
3.7.3 Latin America Crizotinib API Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Crizotinib API Market Facts & Figures by Country
3.8.1 Middle East and Africa Crizotinib API Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Crizotinib API Sales by Country (2021–2032)
3.8.3 Middle East and Africa Crizotinib API Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Crizotinib API Sales by Type (2021–2032)
4.1.1 Global Crizotinib API Sales by Type (2021–2026)
4.1.2 Global Crizotinib API Sales by Type (2027–2032)
4.1.3 Global Crizotinib API Sales Market Share by Type (2021–2032)
4.2 Global Crizotinib API Revenue by Type (2021–2032)
4.2.1 Global Crizotinib API Revenue by Type (2021–2026)
4.2.2 Global Crizotinib API Revenue by Type (2027–2032)
4.2.3 Global Crizotinib API Revenue Market Share by Type (2021–2032)
4.3 Global Crizotinib API Price by Type (2021–2032)
5 Segment by Application
5.1 Global Crizotinib API Sales by Application (2021–2032)
5.1.1 Global Crizotinib API Sales by Application (2021–2026)
5.1.2 Global Crizotinib API Sales by Application (2027–2032)
5.1.3 Global Crizotinib API Sales Market Share by Application (2021–2032)
5.2 Global Crizotinib API Revenue by Application (2021–2032)
5.2.1 Global Crizotinib API Revenue by Application (2021–2026)
5.2.2 Global Crizotinib API Revenue by Application (2027–2032)
5.2.3 Global Crizotinib API Revenue Market Share by Application (2021–2032)
5.3 Global Crizotinib API Price by Application (2021–2032)
6 Key Companies Profiled
6.1 MSN Laboratories
6.1.1 MSN Laboratories Company Information
6.1.2 MSN Laboratories Description and Business Overview
6.1.3 MSN Laboratories Crizotinib API Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 MSN Laboratories Crizotinib API Product Portfolio
6.1.5 MSN Laboratories Recent Developments/Updates
6.2 Greencross
6.2.1 Greencross Company Information
6.2.2 Greencross Description and Business Overview
6.2.3 Greencross Crizotinib API Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Greencross Crizotinib API Product Portfolio
6.2.5 Greencross Recent Developments/Updates
6.3 Hetero Labs
6.3.1 Hetero Labs Company Information
6.3.2 Hetero Labs Description and Business Overview
6.3.3 Hetero Labs Crizotinib API Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Hetero Labs Crizotinib API Product Portfolio
6.3.5 Hetero Labs Recent Developments/Updates
6.4 Vama Lifecare
6.4.1 Vama Lifecare Company Information
6.4.2 Vama Lifecare Description and Business Overview
6.4.3 Vama Lifecare Crizotinib API Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Vama Lifecare Crizotinib API Product Portfolio
6.4.5 Vama Lifecare Recent Developments/Updates
6.5 Croissance Biomed
6.5.1 Croissance Biomed Company Information
6.5.2 Croissance Biomed Description and Business Overview
6.5.3 Croissance Biomed Crizotinib API Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Croissance Biomed Crizotinib API Product Portfolio
6.5.5 Croissance Biomed Recent Developments/Updates
6.6 Medicine House
6.6.1 Medicine House Company Information
6.6.2 Medicine House Description and Business Overview
6.6.3 Medicine House Crizotinib API Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Medicine House Crizotinib API Product Portfolio
6.6.5 Medicine House Recent Developments/Updates
6.7 Apothecon Pharmaceuticals
6.7.1 Apothecon Pharmaceuticals Company Information
6.7.2 Apothecon Pharmaceuticals Description and Business Overview
6.7.3 Apothecon Pharmaceuticals Crizotinib API Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Apothecon Pharmaceuticals Crizotinib API Product Portfolio
6.7.5 Apothecon Pharmaceuticals Recent Developments/Updates
6.8 Tocris Bioscience
6.8.1 Tocris Bioscience Company Information
6.8.2 Tocris Bioscience Description and Business Overview
6.8.3 Tocris Bioscience Crizotinib API Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Tocris Bioscience Crizotinib API Product Portfolio
6.8.5 Tocris Bioscience Recent Developments/Updates
6.9 Selleck Chemicals
6.9.1 Selleck Chemicals Company Information
6.9.2 Selleck Chemicals Description and Business Overview
6.9.3 Selleck Chemicals Crizotinib API Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Selleck Chemicals Crizotinib API Product Portfolio
6.9.5 Selleck Chemicals Recent Developments/Updates
6.10 Cayman Chemical
6.10.1 Cayman Chemical Company Information
6.10.2 Cayman Chemical Description and Business Overview
6.10.3 Cayman Chemical Crizotinib API Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Cayman Chemical Crizotinib API Product Portfolio
6.10.5 Cayman Chemical Recent Developments/Updates
6.11 Anant Pharmaceuticals
6.11.1 Anant Pharmaceuticals Company Information
6.11.2 Anant Pharmaceuticals Description and Business Overview
6.11.3 Anant Pharmaceuticals Crizotinib API Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Anant Pharmaceuticals Crizotinib API Product Portfolio
6.11.5 Anant Pharmaceuticals Recent Developments/Updates
6.12 Adooq Bioscience
6.12.1 Adooq Bioscience Company Information
6.12.2 Adooq Bioscience Description and Business Overview
6.12.3 Adooq Bioscience Crizotinib API Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Adooq Bioscience Crizotinib API Product Portfolio
6.12.5 Adooq Bioscience Recent Developments/Updates
6.13 Focus Biomolecules
6.13.1 Focus Biomolecules Company Information
6.13.2 Focus Biomolecules Description and Business Overview
6.13.3 Focus Biomolecules Crizotinib API Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Focus Biomolecules Crizotinib API Product Portfolio
6.13.5 Focus Biomolecules Recent Developments/Updates
6.14 LC Laboratories
6.14.1 LC Laboratories Company Information
6.14.2 LC Laboratories Description and Business Overview
6.14.3 LC Laboratories Crizotinib API Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 LC Laboratories Crizotinib API Product Portfolio
6.14.5 LC Laboratories Recent Developments/Updates
6.15 Hefei Home Sunshine Pharmaceutical Technology
6.15.1 Hefei Home Sunshine Pharmaceutical Technology Company Information
6.15.2 Hefei Home Sunshine Pharmaceutical Technology Description and Business Overview
6.15.3 Hefei Home Sunshine Pharmaceutical Technology Crizotinib API Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Hefei Home Sunshine Pharmaceutical Technology Crizotinib API Product Portfolio
6.15.5 Hefei Home Sunshine Pharmaceutical Technology Recent Developments/Updates
6.16 Chongqing Huapont Shengchem Pharm
6.16.1 Chongqing Huapont Shengchem Pharm Company Information
6.16.2 Chongqing Huapont Shengchem Pharm Description and Business Overview
6.16.3 Chongqing Huapont Shengchem Pharm Crizotinib API Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Chongqing Huapont Shengchem Pharm Crizotinib API Product Portfolio
6.16.5 Chongqing Huapont Shengchem Pharm Recent Developments/Updates
6.17 Xuzhou Wanbang Jinqiao Pharmaceutical
6.17.1 Xuzhou Wanbang Jinqiao Pharmaceutical Company Information
6.17.2 Xuzhou Wanbang Jinqiao Pharmaceutical Description and Business Overview
6.17.3 Xuzhou Wanbang Jinqiao Pharmaceutical Crizotinib API Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Xuzhou Wanbang Jinqiao Pharmaceutical Crizotinib API Product Portfolio
6.17.5 Xuzhou Wanbang Jinqiao Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Crizotinib API Industry Chain Analysis
7.2 Crizotinib API Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Crizotinib API Production Mode & Process Analysis
7.4 Crizotinib API Sales and Marketing
7.4.1 Crizotinib API Sales Channels
7.4.2 Crizotinib API Distributors
7.5 Crizotinib API Customer Analysis
8 Crizotinib API Market Dynamics
8.1 Crizotinib API Industry Trends
8.2 Crizotinib API Market Drivers
8.3 Crizotinib API Market Challenges
8.4 Crizotinib API Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
MSN Laboratories
Greencross
Hetero Labs
Apothecon Pharmaceuticals
Tocris Bioscience
Selleck Chemicals
Cayman Chemical
Anant Pharmaceuticals
AdooQ BioScience
Focus Biomolecules
LC Laboratories
Hefei Home Sunshine Pharmaceutical Technology
Vama Lifecare
Croissance Biomed
Medicine House
Chongqing Huapont Shengchem Pharm
Xuzhou Wanbang Jinqiao Pharmaceutical
List of Tables
 Table 1. Global Crizotinib API Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Crizotinib API Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Crizotinib API Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Crizotinib API Sales (kg) of Key Manufacturers (2021–2026)
 Table 5. Global Crizotinib API Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Crizotinib API Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Crizotinib API Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Crizotinib API Average Price (US$/kg) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Crizotinib API, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Crizotinib API, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Crizotinib API, Product Types and Applications
 Table 12. Global Key Manufacturers of Crizotinib API, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Crizotinib API Companies by Tier (Tier 1, Tier 2, Tier 3), based on Crizotinib API Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Crizotinib API Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Crizotinib API Sales by Region (kg), 2021–2026
 Table 18. Global Crizotinib API Sales Market Share by Region (2021–2026)
 Table 19. Global Crizotinib API Sales by Region (kg), 2027–2032
 Table 20. Global Crizotinib API Sales Market Share by Region (2027–2032)
 Table 21. Global Crizotinib API Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Crizotinib API Revenue Market Share by Region (2021–2026)
 Table 23. Global Crizotinib API Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Crizotinib API Revenue Market Share by Region (2027–2032)
 Table 25. North America Crizotinib API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Crizotinib API Sales by Country (kg), 2021–2026
 Table 27. North America Crizotinib API Sales by Country (kg), 2027–2032
 Table 28. North America Crizotinib API Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Crizotinib API Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Crizotinib API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Crizotinib API Sales by Country (kg), 2021–2026
 Table 32. Europe Crizotinib API Sales by Country (kg), 2027–2032
 Table 33. Europe Crizotinib API Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Crizotinib API Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Crizotinib API Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Crizotinib API Sales by Region (kg), 2021–2026
 Table 37. Asia Pacific Crizotinib API Sales by Region (kg), 2027–2032
 Table 38. Asia Pacific Crizotinib API Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Crizotinib API Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Crizotinib API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Crizotinib API Sales by Country (kg), 2021–2026
 Table 42. Latin America Crizotinib API Sales by Country (kg), 2027–2032
 Table 43. Latin America Crizotinib API Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Crizotinib API Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Crizotinib API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Crizotinib API Sales by Country (kg), 2021–2026
 Table 47. Middle East and Africa Crizotinib API Sales by Country (kg), 2027–2032
 Table 48. Middle East and Africa Crizotinib API Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Crizotinib API Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Crizotinib API Sales (kg) by Type (2021–2026)
 Table 51. Global Crizotinib API Sales (kg) by Type (2027–2032)
 Table 52. Global Crizotinib API Sales Market Share by Type (2021–2026)
 Table 53. Global Crizotinib API Sales Market Share by Type (2027–2032)
 Table 54. Global Crizotinib API Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Crizotinib API Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Crizotinib API Revenue Market Share by Type (2021–2026)
 Table 57. Global Crizotinib API Revenue Market Share by Type (2027–2032)
 Table 58. Global Crizotinib API Price (US$/kg) by Type (2021–2026)
 Table 59. Global Crizotinib API Price (US$/kg) by Type (2027–2032)
 Table 60. Global Crizotinib API Sales (kg) by Application (2021–2026)
 Table 61. Global Crizotinib API Sales (kg) by Application (2027–2032)
 Table 62. Global Crizotinib API Sales Market Share by Application (2021–2026)
 Table 63. Global Crizotinib API Sales Market Share by Application (2027–2032)
 Table 64. Global Crizotinib API Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Crizotinib API Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Crizotinib API Revenue Market Share by Application (2021–2026)
 Table 67. Global Crizotinib API Revenue Market Share by Application (2027–2032)
 Table 68. Global Crizotinib API Price (US$/kg) by Application (2021–2026)
 Table 69. Global Crizotinib API Price (US$/kg) by Application (2027–2032)
 Table 70. MSN Laboratories Company Information
 Table 71. MSN Laboratories Description and Business Overview
 Table 72. MSN Laboratories Crizotinib API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 73. MSN Laboratories Crizotinib API Product
 Table 74. MSN Laboratories Recent Developments/Updates
 Table 75. Greencross Company Information
 Table 76. Greencross Description and Business Overview
 Table 77. Greencross Crizotinib API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 78. Greencross Crizotinib API Product
 Table 79. Greencross Recent Developments/Updates
 Table 80. Hetero Labs Company Information
 Table 81. Hetero Labs Description and Business Overview
 Table 82. Hetero Labs Crizotinib API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 83. Hetero Labs Crizotinib API Product
 Table 84. Hetero Labs Recent Developments/Updates
 Table 85. Vama Lifecare Company Information
 Table 86. Vama Lifecare Description and Business Overview
 Table 87. Vama Lifecare Crizotinib API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 88. Vama Lifecare Crizotinib API Product
 Table 89. Vama Lifecare Recent Developments/Updates
 Table 90. Croissance Biomed Company Information
 Table 91. Croissance Biomed Description and Business Overview
 Table 92. Croissance Biomed Crizotinib API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 93. Croissance Biomed Crizotinib API Product
 Table 94. Croissance Biomed Recent Developments/Updates
 Table 95. Medicine House Company Information
 Table 96. Medicine House Description and Business Overview
 Table 97. Medicine House Crizotinib API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 98. Medicine House Crizotinib API Product
 Table 99. Medicine House Recent Developments/Updates
 Table 100. Apothecon Pharmaceuticals Company Information
 Table 101. Apothecon Pharmaceuticals Description and Business Overview
 Table 102. Apothecon Pharmaceuticals Crizotinib API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 103. Apothecon Pharmaceuticals Crizotinib API Product
 Table 104. Apothecon Pharmaceuticals Recent Developments/Updates
 Table 105. Tocris Bioscience Company Information
 Table 106. Tocris Bioscience Description and Business Overview
 Table 107. Tocris Bioscience Crizotinib API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 108. Tocris Bioscience Crizotinib API Product
 Table 109. Tocris Bioscience Recent Developments/Updates
 Table 110. Selleck Chemicals Company Information
 Table 111. Selleck Chemicals Description and Business Overview
 Table 112. Selleck Chemicals Crizotinib API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 113. Selleck Chemicals Crizotinib API Product
 Table 114. Selleck Chemicals Recent Developments/Updates
 Table 115. Cayman Chemical Company Information
 Table 116. Cayman Chemical Description and Business Overview
 Table 117. Cayman Chemical Crizotinib API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 118. Cayman Chemical Crizotinib API Product
 Table 119. Cayman Chemical Recent Developments/Updates
 Table 120. Anant Pharmaceuticals Company Information
 Table 121. Anant Pharmaceuticals Description and Business Overview
 Table 122. Anant Pharmaceuticals Crizotinib API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 123. Anant Pharmaceuticals Crizotinib API Product
 Table 124. Anant Pharmaceuticals Recent Developments/Updates
 Table 125. Adooq Bioscience Company Information
 Table 126. Adooq Bioscience Description and Business Overview
 Table 127. Adooq Bioscience Crizotinib API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 128. Adooq Bioscience Crizotinib API Product
 Table 129. Adooq Bioscience Recent Developments/Updates
 Table 130. Focus Biomolecules Company Information
 Table 131. Focus Biomolecules Description and Business Overview
 Table 132. Focus Biomolecules Crizotinib API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 133. Focus Biomolecules Crizotinib API Product
 Table 134. Focus Biomolecules Recent Developments/Updates
 Table 135. LC Laboratories Company Information
 Table 136. LC Laboratories Description and Business Overview
 Table 137. LC Laboratories Crizotinib API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 138. LC Laboratories Crizotinib API Product
 Table 139. LC Laboratories Recent Developments/Updates
 Table 140. Hefei Home Sunshine Pharmaceutical Technology Company Information
 Table 141. Hefei Home Sunshine Pharmaceutical Technology Description and Business Overview
 Table 142. Hefei Home Sunshine Pharmaceutical Technology Crizotinib API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 143. Hefei Home Sunshine Pharmaceutical Technology Crizotinib API Product
 Table 144. Hefei Home Sunshine Pharmaceutical Technology Recent Developments/Updates
 Table 145. Chongqing Huapont Shengchem Pharm Company Information
 Table 146. Chongqing Huapont Shengchem Pharm Description and Business Overview
 Table 147. Chongqing Huapont Shengchem Pharm Crizotinib API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 148. Chongqing Huapont Shengchem Pharm Crizotinib API Product
 Table 149. Chongqing Huapont Shengchem Pharm Recent Developments/Updates
 Table 150. Xuzhou Wanbang Jinqiao Pharmaceutical Company Information
 Table 151. Xuzhou Wanbang Jinqiao Pharmaceutical Description and Business Overview
 Table 152. Xuzhou Wanbang Jinqiao Pharmaceutical Crizotinib API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 153. Xuzhou Wanbang Jinqiao Pharmaceutical Crizotinib API Product
 Table 154. Xuzhou Wanbang Jinqiao Pharmaceutical Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. Crizotinib API Distributors List
 Table 158. Crizotinib API Customers List
 Table 159. Crizotinib API Market Trends
 Table 160. Crizotinib API Market Drivers
 Table 161. Crizotinib API Market Challenges
 Table 162. Crizotinib API Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Crizotinib API
 Figure 2. Global Crizotinib API Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Crizotinib API Market Share by Type: 2025 & 2032
 Figure 4. Purity≥99% Product Picture
 Figure 5. Purity<99% Product Picture
 Figure 6. Global Crizotinib API Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Crizotinib API Market Share by Application: 2025 & 2032
 Figure 8. Online Sales
 Figure 9. Offline Sales
 Figure 10. Global Crizotinib API Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Crizotinib API Market Size (US$ Million), 2021–2032
 Figure 12. Global Crizotinib API Sales (kg), 2021–2032
 Figure 13. Global Crizotinib API Average Price (US$/kg), 2021–2032
 Figure 14. Crizotinib API Report Years Considered
 Figure 15. Crizotinib API Sales Share by Manufacturers in 2025
 Figure 16. Global Crizotinib API Revenue Share by Manufacturers in 2025
 Figure 17. Top 5 and Top 10 Global Crizotinib API Players: Market Share by Revenue in Crizotinib API in 2025
 Figure 18. Crizotinib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 19. Global Crizotinib API Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 20. North America Crizotinib API Sales Market Share by Country (2021–2032)
 Figure 21. North America Crizotinib API Revenue Market Share by Country (2021–2032)
 Figure 22. United States Crizotinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 23. Canada Crizotinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Europe Crizotinib API Sales Market Share by Country (2021–2032)
 Figure 25. Europe Crizotinib API Revenue Market Share by Country (2021–2032)
 Figure 26. Germany Crizotinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. France Crizotinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. U.K. Crizotinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Italy Crizotinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Russia Crizotinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Asia Pacific Crizotinib API Sales Market Share by Region (2021–2032)
 Figure 32. Asia Pacific Crizotinib API Revenue Market Share by Region (2021–2032)
 Figure 33. China Crizotinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Japan Crizotinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. South Korea Crizotinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. India Crizotinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Australia Crizotinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. China Taiwan Crizotinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Southeast Asia Crizotinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Latin America Crizotinib API Sales Market Share by Country (2021–2032)
 Figure 41. Latin America Crizotinib API Revenue Market Share by Country (2021–2032)
 Figure 42. Mexico Crizotinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Brazil Crizotinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Argentina Crizotinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Colombia Crizotinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Middle East and Africa Crizotinib API Sales Market Share by Country (2021–2032)
 Figure 47. Middle East and Africa Crizotinib API Revenue Market Share by Country (2021–2032)
 Figure 48. Turkey Crizotinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Saudi Arabia Crizotinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. UAE Crizotinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Global Sales Market Share of Crizotinib API by Type (2021–2032)
 Figure 52. Global Revenue Market Share of Crizotinib API by Type (2021–2032)
 Figure 53. Global Crizotinib API Price (US$/kg) by Type (2021–2032)
 Figure 54. Global Sales Market Share of Crizotinib API by Application (2021–2032)
 Figure 55. Global Revenue Market Share of Crizotinib API by Application (2021–2032)
 Figure 56. Global Crizotinib API Price (US$/kg) by Application (2021–2032)
 Figure 57. Crizotinib API Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Crizotinib Drugs Market Research Report 2024
Global Ceritinib API Market Research Report 2024
Global Icotinib API Market Research Report 2024
Global Brigatinib API Market Research Report 2024
Global Afatinib API Market Research Report 2024
Global Crizotinib Market Research Report 2024
Global Oncology API Market Research Report 2024
Global MET TKIs Market Research Report 2024
Alectinib Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global ALK Inhibitors Market Research Report 2024
Global Olaparib API Market Research Report 2024
Sorafenib Tosylate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Saracatinib Market Research Report 2024
Global Dacomitinib API Market Research Report 2024
Global Crizotinib Capsules Market Research Report 2024
Global Pazopanib API Market Research Report 2025
Global Niraparib API Market Research Report 2024
Bosutinib API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Savolitinib Tablets Market Research Report 2024
Abrocitinib API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions